An FDA-approved clinical trial is the first to show that treating patients with adult stem cells after a heart attack is safe and that it appears to repair damaged heart tissue. Results of the study are published in the December 8 issue of the Journal of the American College of Cardiology.

Read the entire UM release here.

Leave a Reply

Your email address will not be published. Required fields are marked *